Similar Search Results

Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphom...

Uyl-de Groot, Carin A.; Ossenkoppele, Gert J.; Buijt, Ivanne - In: PharmacoEconomics 15 (1999) 3, pp. 305-311

Objective: The aim of this paper is to compare the costs of autologous bone marrow transplantation (ABMT) and whole blood transplantation in patients with relapsed or poorly responding non-Hodgkin's lymphoma. Design and setting: In a retrospective study, we calculated the treatment costs of 40...

Persistent link: https://www.econbiz.de/10005449312

What is the Role of Stroke Units in Overall Care?

Hickey, Joanne V.; Grotta, James C. - In: Disease Management and Health Outcomes 6 (1999) 4, pp. 193-202

Stroke is a heterogeneous cerebrovascular disorder that is a major cause of death and disability in the industrialised world. Anecdotal clinical evidence and expert opinion has suggested that organised stroke care results in better patient outcomes compared with care provided in general medical...

Persistent link: https://www.econbiz.de/10005404641

Le Pen, Claude; Berdeaux, Gilles - In: PharmacoEconomics 17 (2000) 2, pp. 115-120

The availability of the Diagnosis Related Group (DRG) system for determining hospital costs in some European countries has encouraged its use in pharmacoeconomic evaluations. The DRG system was developed in the US to provide data for prospective payments for hospitals. However, the financing of...

Persistent link: https://www.econbiz.de/10005404858

Predicting Hospitalisation of Patients with Diabetes Mellitus: An Application of the Bayesian Discriminant Analysis

Bhattacharyya, Samir K. - In: PharmacoEconomics 13 (1998) 5, pp. 519-529

identifying both the personal and the healthcare system characteristics predictive of hospitalisation for the treatment of … probability of one or more hospitalisation events among patients with diabetes. The study used claims data extracted from the … predictive of 1 or more hospitalisation events. The model shows a predictive power of almost 90%. This study found that …

Persistent link: https://www.econbiz.de/10005404891

Estimating Influenza-Related Hospital Admissions in Children and Adults: A Time Series Analysis

Scuffham, Paul A. - In: Disease Management and Health Outcomes 11 (2003) 4, pp. 259-269

Introduction: Influenza is associated with illnesses such as pneumonia and other respiratory conditions and in severe cases leads to death. The prevalence of these illnesses and deaths fluctuates with the seasons during the year, even in the absence of influenza. Although many studies have...

Persistent link: https://www.econbiz.de/10005590161

Hospital Length of Stay for Schizophrenia: Is Primary Payer an Influencing Factor?

Sclar, David A.; Robison, Linda M.; Skaer, Tracy L.; … - In: Disease Management and Health Outcomes 5 (1999) 6, pp. 339-347

schizophrenia and requiring a hospitalisation in the calendar year 1988 or 1992, by primary payer type (Medicare; Medicaid; or …

Persistent link: https://www.econbiz.de/10005590212

Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections

Holliday, Stephen M.; Benfield, Paul - In: PharmacoEconomics 13 (1998) 3, pp. 359-377

Meropenem is a carbapenem antibiotic which is active against the majority of aerobic and anaerobic bacteria implicated in serious infections. Its therapeutic efficacy in a wide range of serious infections is similar to that of imipenem/cilastatin and standard combination drug regimens. Hence,...

Persistent link: https://www.econbiz.de/10005590296

Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson's Disease

Le Pen, Claude; Wait, Suzanne; Moutard-Martin, Frederic; … - In: PharmacoEconomics 16 (1999) 1, pp. 59-69

Objective: To assess the relationship between severity and progression of illness in Parkinson's disease and the use of healthcare resources. Design and setting: This was a prospective cost-of-illness study conducted in France based on clinical observation over a 6-month period of patients with...

Persistent link: https://www.econbiz.de/10005590382

Cost Comparison of Antibacterial Therapies for Serious Infections: A New Zealand 3-Hospital Study

Scott, W. Guy; Scott, Helen M.; Henderson, Seton; … - In: PharmacoEconomics 16 (1999) 2, pp. 183-192

Objective: The first aim was to identify and determine the economic costs of the regimens currently used in 3 New Zealand hospitals in the treatment of bacterial infections in haematology patients with febrile neutropenia and in intensive care patients with severe infections. The second was to...

Persistent link: https://www.econbiz.de/10005590387

Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care: An Overview and Cost Analysis

Anderson, Craig; Ni Mhurchu, Cliona; Brown, Paul M.; … - In: PharmacoEconomics 20 (2002) 8, pp. 537-552

Background: Limited information exists on the best way to organise stroke rehabilitation after hospital discharge and the relative costs of such services. Objective: To review the evidence of the cost effectiveness of services that accelerate hospital discharge and provide home-based...

Persistent link: https://www.econbiz.de/10005590399